These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36148906)

  • 21. Sabin polio virus protein 1 (VP1) evolution in patients with acute flaccid paralysis from 2010 to 2016 in Uganda.
    Nanteza MB; Bakamutumaho B; Tushabe P; Namuwulya P; Birungi M; Dhatemwa R; Eliku JP; Tibanagwa M; Kakooza P; Bukenya H; Bwogi J; Byabamazima CR
    Virol J; 2023 Aug; 20(1):172. PubMed ID: 37533043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021.
    Chirlaque López MD; Cabrerizo M; Guzmán Herrador BR; Masa-Calles J; Alarcón-Linares ME; Allende A; Aznar Cano E; Barranco Boada MI; Cantero Gudino E; Fernández-Balbuena S; Fernández Dueñas A; Fernández-García MD; García Hernández L; García Ortúzar V; López-Perea N; Martínez-Salcedo E; Moreno-Docón A; Ordobás Gavín M; Rodero Garduño I; Sierra Moros MJ; Simón Soria F; Limia Sánchez A; Suárez Rodríguez B
    Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019.
    Macklin G; Diop OM; Humayun A; Shahmahmoodi S; El-Sayed ZA; Triki H; Rey G; Avagyan T; Grabovac V; Jorba J; Farag N; Mach O
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(28):913-917. PubMed ID: 32673297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
    Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
    Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of type 2 vaccine-derived poliovirus outbreaks between 2016 and 2020.
    Macklin GR; Goel AK; Mach O; Tallis G; Ahmed JA; O'Reilly KM; Grassly NC; Diop OM
    Vaccine; 2023 Apr; 41 Suppl 1():A19-A24. PubMed ID: 36008232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study.
    O'Reilly KM; Verity R; Durry E; Asghar H; Sharif S; Zaidi SZ; Wadood MZM; Diop OM; Okayasu H; Safdar RM; Grassly NC
    BMC Infect Dis; 2018 Apr; 18(1):176. PubMed ID: 29653509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strengthened surveillance revealed a rapid disappearance of the poliovirus serotype 2 vaccine strain in Madagascar after its removal from the oral polio vaccine.
    Razafindratsimandresy R; Joffret ML; Raharinantoanina J; Polston P; Andriamamonjy NS; Razanajatovo IM; Diop OM; Delpeyroux F; Héraud JM; Bessaud M
    J Med Virol; 2022 Dec; 94(12):5877-5884. PubMed ID: 35977919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
    Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
    BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating surveillance indicators supporting the Global Polio Eradication Initiative, 2011-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Apr; 62(14):270-4. PubMed ID: 23575241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.
    Pons-Salort M; Molodecky NA; O'Reilly KM; Wadood MZ; Safdar RM; Etsano A; Vaz RG; Jafari H; Grassly NC; Blake IM
    PLoS Med; 2016 Oct; 13(10):e1002140. PubMed ID: 27701425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological survey and genetic characterization of type 3 vaccine-derived poliovirus isolated from a patient with four doses of inactivated polio vaccine in Henan Province, China.
    Zhang M; Yang J; Bai Y; Zhu H; Wang C; Zhang L; Xu J; Lu M; Zhang X; Xiao Z; Ma Y; Wang Y; Li X; Wang D; Zhu S; Yan D; Xu W; Zhang Y; Zhang Y
    Infect Dis Poverty; 2022 Dec; 11(1):124. PubMed ID: 36514167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.
    Guo J; Bolivar-Wagers S; Srinivas N; Holubar M; Maldonado Y
    Vaccine; 2015 Mar; 33(10):1235-42. PubMed ID: 25600519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory surveillance for wild and vaccine-derived polioviruses--worldwide, January 2006-June 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):965-9. PubMed ID: 17882127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015.
    Diop OM; Burns CC; Sutter RW; Wassilak SG; Kew OM;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):640-6. PubMed ID: 26086635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.
    Huang QS; Greening G; Baker MG; Grimwood K; Hewitt J; Hulston D; van Duin L; Fitzsimons A; Garrett N; Graham D; Lennon D; Shimizu H; Miyamura T; Pallansch MA
    Lancet; 2005 Jul 30-Aug 5; 366(9483):394-6. PubMed ID: 16054940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of quantitative environmental surveillance in poliovirus eradication strategies.
    Lodder WJ; Buisman AM; Rutjes SA; Heijne JC; Teunis PF; de Roda Husman AM
    Appl Environ Microbiol; 2012 Jun; 78(11):3800-5. PubMed ID: 22447593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory surveillance for wild and vaccine-derived polioviruses - worldwide, January 2008-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(34):950-4. PubMed ID: 19730408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.